Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ï¿¥195,470.38, with a 24-hour trading volume of ï¿¥441.62B. The asset's market cap is ï¿¥174.3T, after moving 0.03% in the last day.
Tokenized Eli Lilly And Co is trading at ï¿¥196,126.35, with a tokenized market cap of ï¿¥7.63B and a 24-hour trading volume of ï¿¥357.52M. The tokenized asset has moved 1.42% in the past 24 hours.